Cenker, 2017 - Google Patents

Differential HIV-1 Susceptibility of Primary Macrophage Populations

Cenker, 2017

View PDF
Document ID
7401299677449761121
Author
Cenker J
Publication year

External Links

Snippet

Macrophages are a target of HIV-1 infection and may serve as an important reservoir of the virus in the body, particularly after depletion of CD4+ T cells in HIV/AIDS. Recently, SAMHD1 was identified as the major restriction factor of HIV-1 infection in myeloid cells. SAMHD1 is …
Continue reading at etd.ohiolink.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Similar Documents

Publication Publication Date Title
Cenker et al. Brain microglial cells are highly susceptible to HIV-1 infection and spread
Sol et al. Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2
Jiang et al. The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability
US20130183334A1 (en) Lentiviral vectors and methods of use thereof
Chauveau et al. HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells
Sorin et al. Dynamics of virus-host interplay in HIV-1 replication
Cenker Differential HIV-1 Susceptibility of Primary Macrophage Populations
Painter Mechanisms of Human Immunodeficiency Virus (HIV) Persistence and Strategies to Elicit Cytotoxic T Lymphocyte-Mediated Clearance of HIV-Infected Cells
Rustanti Combating human immunodeficiency virus replication by gene therapy
Ajasin CCL2 Mobilizes ALIX from Actin Cytoskeleton to Enhance Gag Trafficking and HIV Virion Release-Effect of Gag polymorphism on HIV-1 Viral Fitness
Rainho Examining The Role of Nef in the Resistance of SIV-Infected Macrophages to CD8+ T Cell Suppression
Tavakoli-Tameh Lentiviral Resistance to Tetherin and SERINC5
Alshammary Analysis of the TLR7/8-Induced Block to HIV-1 Replication
Pušnik Helper T cell and B cell responses during the natural course of HIV infection
Featherstone The Antiviral Mechanism of SERINC5 on HIV-1 Infection
de Sousa Pereira Is the European Rabbit (Oryctolagus Cuniculus) a Good Animal Model to Study HIV-1 Pathogenesis and Virus-Host Interactions?
Davis Let us know how access to this document benefits you.
Ibrahim Functional Analysis of HIV-2 Vpx Protein: Multiple
Ciftci Halil Functional Analysis of HIV-2 Vpx Protein: Multiple Roles of the Poly-proline Motif
Ran Roles of HIV virion-associated envelope glycoprotein in modulating various cellular pathways and facilitating viral replication and its pathogenicity
Stultz Visualization of the Intracellular HIV-1 Replication Cycle
Alsahafi HIV-1 ENVELOPE GLYCOPROTEINS SAMPLE A NEW CONFORMATION VULNERABLE TO ANTIBODY ATTACK
Dai SERINC5: Its Sensitivity to Nef and Restriction of HIV-1
Marchant Characterisation of a post-entry restriction to HIV in human cells
Kochar Identification and Characterization of HIV-1 antagonists to the antiviral protein, HERC5